Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abatacept, abbvie, adalimumab, Alamira, analyze, analyzing, ANCOVA, antirheumatic, arguable, asymptomatic, baricitinib, biosimilar, BMS, Bulgaria, buyer, CA, calibrated, Canaan, cartilage, checkpoint, CI, collagen, commensurate, Condensed, contextual, continental, corroborated, COSO, counterparty, Covadonga, COVID, crossover, Crowson, CSO, CT, deficiency, dominated, Dominik, Eastern, elicit, Erroneously, etanercept, evidencing, Faculty, fiinancial, geopolitical, Haleon, HDM, headband, Humira, humoral, Hunter, hydroxychloroquine, immaterial, incorrectly, incursion, inflation, infliximab, influx, Insudpharma, interval, irrevocable, JAK, Jolla, Leader, legacy, lent, Limm, Lysek, Macedonia, Madrid, Melbourne, men, methotrexate, mineral, NASAR, neuroimmune, neuropathy, noninvasive, nonrefundable, Otolith, Otorhinolaryngology, Parliament, PCR, Pfizer, pocket, polyKRASmut, polyvalent, QSR, rash, redeem, reformulation, relaunched, Rheumatism, rituximab, segregation, Singh, skin, Spain, stepped, subtracting, sulfasalazine, suppressed, TNF, tocilizumab, tofacitinib, underwent, uninfected, unitary, Universidad, unqualified, untreated, unwitnessed, upadacitinib, UPC, vestibulogenic, women, Zhou
Removed:
ALIM, Alimera, Andrea, ascending, ascertain, attendance, author, Bausch, besylate, BHC, boxed, Calvin, card, cataract, collaborator, College, Colvin, concentration, Conceptual, consultancy, Cornell, count, dedicated, detection, dexamethasone, disadvantaged, discomfort, dropout, eleven, enrolment, felt, formation, India, investigating, labyrinthectomy, lesser, lifted, maximize, modestly, moved, neurectomy, neurology, neutral, NICDC, NYSE, onward, ophthalmic, ophthalmology, Otividex, Otonomy, package, Panel, PC, postponed, precise, processed, proximity, recapitalization, refractive, replace, schwannoma, secured, Sensorion, steroid, surgical, temporarily, throat, transferring, transient, undergo, Valneva, Weill, York
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view